Coagulative system activation and fibrinolytic system inhibition activities arise from tumoral draining vein in colon carcinoma

Thrombosis Research

Volumn 104, Issue 6, 2001, Pages 421-425

  Garcia Avello, Angel ^a   Galindo Alvarez, Julio ^a   Martinez Molina, Enrique ^a   Cesar Perez, Jesus ^a   Navarro, Jose Luis ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Cancer; Hypercoagulability; Hyperfibrinolysis; Hypofibrinolysis

Indexed keywords

ANTIPLASMIN; ANTITHROMBIN III; D DIMER; PLASMINOGEN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; PROTEIN C;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD LEVEL; BLOOD SAMPLING; CANCER SURGERY; CIRCULATION; CLINICAL ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HUMAN; HYPERCOAGULABILITY; INHIBITION KINETICS; MALE; METHODOLOGY; PERIPHERAL VEIN; PRIORITY JOURNAL; THROMBOCYTOPENIA; TUMOR; TUMOR VASCULARIZATION;

AGED; ANTITHROMBIN III; BIOLOGICAL MARKERS; BLOOD COAGULATION; COLONIC NEOPLASMS; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; HUMANS; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOPHILIA; TISSUE PLASMINOGEN ACTIVATOR; VEINS;

EID: 0035894611     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00383-8     Document Type: Article

References (21)

1. Trousseau syndrome
2. Thrombosis in patients with cancer
3. Unexpectedly high rate of phlebographic deep venous thrombosis following elective general abdominal surgery among patients given prophylaxis with low molecular weight heparin
4. Fibrinolytic shutdown after surgery: Impairment of the balance between tissue-type plasminogen activator and its specific inhibitor
5. Photometric assay of antithrombin III with a chromogenic substrate
6. Fast functional protein C assay using Protac, a novel protein C activator
7. Methods for determination of plasmin-antiplasmin and plasminogen by means of substrate S-2251
8. Laboratory and clinical evaluation of an assay of thrombin-antithrombin III complexes in plasma
9. Quantitation of tissue plasminogen activator in endothelial cultures by use of an enzyme immunoassay
10. Measurement of plasminogen activator inhibitor 1 in biological fluids with a murine monoclonal antibody based enzyme linked immunosorbent assay
11. An immunoassay for human D-dimer using monoclonal antibodies
12. A rapid physiological coagulation method for the determination of plasma fibrinogen
13. Evaluation of the coagulation/fibrinolysis balance in patients with colorectal cancer
14. Pre and postoperative state of coagulation and fibrinolysis in plasma of patients with benign and malignant colorectal disease, a preliminary study
15. Extrinsic pathway activation in cancer with high factor VIIa and tissue factor
16. Factor X activating activity in patients with colorectal carcinoma
17. Fibrinolysis and metastasis: The role of plasminogen activator inhibitor-1 (PAI-1) in a model of transgenic mice
18. Postoperative changes in the plasmatic levels of tissue type plasminogen activator and its fast acting inhibitor relationship to deep vein thrombosis and influence of prophylaxis
19. Location of plasminogen activator (PA) and PA inhibitor in human colorectal adenocarcinomas
20. The plasminogen activation system in human colon cancer: Messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumour stroma
21. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas